Skip to main content

Advertisement

Log in

Alteration of miR-362-5p and miR-454-3p expression elicits diverse responses in breast cancer cell lines

  • Short Communication
  • Published:
Molecular Biology Reports Aims and scope Submit manuscript

Abstract

Background

The heterogeneity of breast tumors presents a challenge in disease management, necessitating an understanding of the molecular mechanisms driving breast tumorigenesis. Aberrant expression of microRNAs is known to promote tumor growth and progression. Our previous RNA-sequencing dataset revealed the upregulation of miR-362-5p and miR-454-3p in breast tumors. We investigated potential role of miR-362-5p and miR-454-3p in breast cancer using MDAMB231 and MCF7 cell lines.

Methods and results

The expression of miR-362-5p and miR-454-3p were altered in MCF7 and MDAMB231 using mimics and inhibitors. The effect on cell viability, cell cycle progression and migration was assessed using Alamar blue assay, flow cytometry and wound healing assay. Further, the expression of potential target genes were measured using real-time PCR. Our results indicated that an increased expression of miR-362-5p promoted cell growth and survival in MCF7, but decreased cell migration. In contrast, miR-362-5p overexpression reduced cancer cell growth, survival and migration in MDAMB231. Overexpression of miR-454-3p was oncogenic in both cell lines but suppressed migration in the aggressive cell line MDAMB231.

Conclusion

Two microRNAs, miR-362-5p and miR-454-3p, were evaluated for functional activity in breast cancer cell lines and they showed increased proliferative signals and tumorigenic properties.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Data availability

Data will be made available on request.

References

  1. Bray F, Ferlay J, Soerjomataram I et al (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68:394–424. https://doi.org/10.3322/caac.21492

    Article  PubMed  Google Scholar 

  2. Ellsworth RE, Blackburn HL, Shriver CD et al (2017) Molecular heterogeneity in breast cancer: state of the science and implications for patient care. Semin Cell Dev Biol 64:65–72. https://doi.org/10.1016/j.semcdb.2016.08.025

    Article  CAS  PubMed  Google Scholar 

  3. Peng Y, Croce CM (2016) The role of MicroRNAs in human cancer. Signal Transduct Target Ther 1:15004. https://doi.org/10.1038/sigtrans.2015.4

    Article  PubMed  PubMed Central  Google Scholar 

  4. Rao AKDM, Arvinden VR, Ramasamy D et al (2021) Identification of novel dysregulated circular RNAs in early-stage breast cancer. J Cell Mol Med 25:3912–3921. https://doi.org/10.1111/jcmm.16324

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Ni F, Zhao H, Cui H et al (2014) MicroRNA-362-5p promotes tumor growth and metastasis by targeting CYLD in hepatocellular carcinoma. Cancer Lett 356:809–818. https://doi.org/10.1016/j.canlet.2014.10.041

    Article  CAS  PubMed  Google Scholar 

  6. Zhang X, He Q, Sun L et al (2019) Comparing MicroRNA profilings of purified HER-2-negative and HER-2-positive cells validates miR-362-5p/Sema3A as characteristic molecular change in triple-negative breast cancers. Dis Markers 2019:6057280. https://doi.org/10.1155/2019/6057280

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Ren L, Chen H, Song J et al (2019) MiR-454-3p-mediated Wnt/β-catenin signaling antagonists suppression promotes breast cancer metastasis. Theranostics 9:449–465. https://doi.org/10.7150/thno.29055

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Li Q, Liu J, Meng X et al (2017) MicroRNA-454 may function as an oncogene via targeting AKT in triple negative breast cancer. J Biol Res (Thessalon) 24:10. https://doi.org/10.1186/s40709-017-0067-x

    Article  CAS  Google Scholar 

  9. Chandrashekar DS, Bashel B, Balasubramanya SAH et al (2017) UALCAN: a portal for facilitating tumor subgroup gene expression and survival analyses. Neoplasia 19:649–658. https://doi.org/10.1016/j.neo.2017.05.002

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Suarez-Arnedo A, Torres Figueroa F, Clavijo C et al (2020) An image J plugin for the high throughput image analysis of in vitro scratch wound healing assays. PLoS ONE 15:e0232565. https://doi.org/10.1371/journal.pone.0232565

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Xie S, Zhu Q, Qu W et al (2019) sRNAPrimerDB: comprehensive primer design and search web service for small non-coding RNAs. Bioinformatics 35:1566–1572. https://doi.org/10.1093/bioinformatics/bty852

    Article  CAS  PubMed  Google Scholar 

  12. Cao Z-G, Li J-J, Yao L et al (2016) High expression of microRNA-454 is associated with poor prognosis in triple-negative breast cancer. Oncotarget 7:64900–64909. https://doi.org/10.18632/oncotarget.11764

    Article  PubMed  PubMed Central  Google Scholar 

  13. Smith SE, Mellor P, Ward AK et al (2017) Molecular characterization of breast cancer cell lines through multiple omic approaches. Breast Cancer Res 19:65. https://doi.org/10.1186/s13058-017-0855-0

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Zhu Y, Sullivan LL, Nair SS et al (2006) Coregulation of estrogen receptor by ERBB4/HER4 establishes a growth-promoting autocrine signal in breast tumor cells. Cancer Res 66:7991–7998. https://doi.org/10.1158/0008-5472.CAN-05-4397

    Article  CAS  PubMed  Google Scholar 

  15. Li X, Hou L, Yin L, Zhao S (2020) LncRNA XIST interacts with miR-454 to inhibit cells proliferation, epithelial mesenchymal transition and induces apoptosis in triple-negative breast cancer. J Biosci 45:45

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

The authors thank Dr. Priya Ramanathan and Dr. Hemavathi Dhandapani for supporting with the FACS experiments.

Funding

This study was supported by Department of Biotechnology, Government of India [Grant No.: BT/PR8152/AGR/36/739/2013] and Cancer Institute (WIA), India.

Author information

Authors and Affiliations

Authors

Contributions

Experiments, data analysis and interpretation, and manuscript preparation: AR; Experiments, data analysis, and manuscript preparation: AKDMR; Data analysis and Manuscript preparation: KP and HG, Manuscript preparation: SV; Study Conceptualization: TR; Fund acquisition, Study conceptualization, Experiment design and planning, Result interpretation: SM.

Corresponding author

Correspondence to Samson Mani.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (PPTX 272 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Aarthy, R., Rao, A.K.D.M., Patel, K. et al. Alteration of miR-362-5p and miR-454-3p expression elicits diverse responses in breast cancer cell lines. Mol Biol Rep 49, 821–826 (2022). https://doi.org/10.1007/s11033-021-06873-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11033-021-06873-1

Keywords

Navigation